Let’s be honest, ‘client service’ is one of the most lifeless phrases in our industry. It confines people to their accounts and frames relationships as ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...

Johnson & Johnson (J&J) has announced that it is seeking US Food and Drug Administration (FDA) approval to include new ...

Proactive protection This trend captures a universal human truth – when the world feels uncertain, we cling to what we can ...

The US Food and Drug Administration (FDA) has approved Apellis Pharmaceuticals’ Sobi-partnered Empaveli (pegcetacoplan) to ...